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Synthesis of (2S, Scanned NMR spectra for (2S,3S,4R)-
octadecane-1,3,4-triol (12) S226 Formation of the corresponding urea 19 from amine 17 required the synthesis of an appropriate isocyanate, which would be accessed by a Curtius rearrangement on the corresponding acid azide.
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Synthesis of new CD1d Ligands
Since the hydrophobic A' binding pocket in CD1d optimally accommodates an acyl chain length containing 26 carbon atoms, 10 we chose to use tetracosanoic acid as our starting material as this would be provide a urea product containing 25 atoms in the acyl chain (24 carbons and one nitrogen). Since the α-GalCer analogue containing a C 24 acyl chain displays similar biological activity to α-GalCer containing a C 26 chain, 11 differences in biological activity between a ureido analogue containing 25 atoms in the acyl chain (i.e. 9), and α-GalCer 1, would be a attributable to an amide-urea switch and not the slightly truncated alkyl chain length. Tricosanyl isocyanate was duly prepared from tetracosanoic acid following a procedure from Várová and co-workers, 12 and used, without purification, in a reaction with amine 17 to provide urea 19 in 68% yield. Hydrogenolysis of the benzyl groups in amide 18 and urea 19 effected global deprotection and afforded our first target, urea 9, alongside α-GalCer 1, which would serve as the control in our biological studies (Scheme 1). Since one of the benzyl ethers in the phytosphingosine unit of amide 18 and urea 19 proved to be particularly stubborn to remove, we investigated a phytosphingosine acceptor in which the internal 1,2-diol was protected as an isopropylidene acetal. 13 Galactoside 20 was consequently accessed under our standard conditions in good yield and once again with complete α-stereoselectivity (Scheme 2).
Subsequent Staudinger reduction provided amine 21, which was acylated as before to provide amide ThrCer and ThrCer analogues 11-13: Our attention turned to the synthesis of ThrCer 2 and its three analogues 11, 12 and 13. Ready access to an advanced intermediate, namely amine 26, using a slight modification of our previously established methodology, 16 alongside that developed for generating the three α-GalCer analogues, provided straightforward access to the corresponding ThrCer analogues as summarized in Scheme 3. ThrCer 2 was synthesized from amine 26 in a threestep sequence involving acylation, followed by silyl ether deprotection and acetal hydrolysis. 
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General Experimental
Infra-red spectra were recorded neat as thin films. The intensity of each band is described as s (strong), m (medium) or w (weak) and with the prefix v (very) and suffix br (broad) where appropriate.
1 H-NMR and 13 C-NMR spectra were recorded in the solvent specified, at 500 and 125 Reactions were monitored by thin layer chromatography using pre-coated glass-backed silica plates (60A F 254 ) and visualized by UV detection (at 254 nm) or by staining with ammonium molybdate(IV)-cerium(IV) sulfate staining dip, or 5% phosphomolybdic acid in EtOH (MPA spray), or 1% α-naphthol, 5% H 2 SO 4 in EtOH. Column chromatography was performed on silica gel (particle size 40-63 µm mesh) using standard glass columns or using pre-packed cartridges (silica, particle size 40 µm)
[1 g (6 mL) cartridge size for purifying <30 mg of product, 2 g (12 mL) cartridge size for purifying General procedure for catalytic hydrogenolysis: Pd(OH) 2 /C or Pd/C (0.05 eq per benzyl group) was added to a solution of the benzylated compound in THF (0.01 M). H 2 gas was bubbled through the stirred suspension. The progress of the reaction was monitored by TLC. On completion, the reaction mixture was filtered through a plug of Celite, washed with THF and then CHCl 3 /MeOH (90/10, v/v), and concentrated under reduced pressure to provide the crude product, which was purified by flash column chromatography.
S14 (2S,3S,4R)-1-O-(α-D-Galactopyranosyl)-2-(tricosanylaminocarbonylamino)octadecane-1,3,4-triol (9)
Urea 9 2S,3S,4R)-3,4-O-Isopropylidene-1-O-(2',3',4',6'-tetra-O-benzyl-α-D-galactopyranosyl) 
S23 (2S,3R,4R)-2-Azido-3,4-di-O-benzyl-1-O-(2',3',4',6'-tetra-O-benzyl-α-Dgalactopyranosyl)octadecane-1,3,4-triol (16)
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crude product, which was purified by flash column chromatography (35% EtOAc in hexane) to afford amine 17 as a white solid (300 mg, 72%), which was used directly without further purification. prepared by a different route.
(2S,3S,4R)-1-O-α-D-galactopyranosyl-2-(hexacosanoylamino)octadecane-1,3,4-triol (α-
GalCer) (1) 21, 22 α-GalCer (1) was prepared according a slightly modified procedure to that reported in the literature: 21 Amide 1 (α-GalCer) was prepared from perbenzylated amide 18 (180 mg, 0.129 mmol)
and Pd/C (85 mg, 10% wet) in THF (10 mL) according to the general procedure. (CH 2 , C-2''), 48.7 (CH, C-2), 69.5 (CH 2 , C-6'), 69.9 (CH, C-5'), 70. 
S32 (2S,3S,4R)-2-Amino-1-O-[4'-O-tert-butyldiphenylsilyl-2',3'-O-isopropylidene-L-threitol]-3,4-Oisopropylidene-octadecane-1,3,4-triol (26)
PMe 3 (0.7 mL of a 1.0 M soln in THF, 0.7 mmol) was added dropwise over 2 min to a solution of (2S,3S,4R)-1-O-[4'-O-tert-Butyldiphenylsilyl-2',3'-O-isopropylidene-L-threitol]-2 40 (s, 6H, C(CH 3 ) 2 ), 1.42 (s, 3H, C(CH 3 ) 2 ), 1.59 (s, 3H, C(CH 3 ) 2 
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The synthesis of ThrCer (2) has been reported previously; 6, 25 however the literature routes employ slightly different protecting group strategies. The synthesis of 2 from 27 is therefore described below. conversion, 1.40 mmol) in THF (5 mL) was added dropwise over 5 min. The resulting solution was stirred at this temperature for 1 h and then at r.t. for 12 h. The reaction was then quenched by the addition of MeOH (2 mL) followed by NaHCO 3 solution (10 mL). The phases were separated and the aqueous phase was extracted with CH 2 Cl 2 (3 × 20 mL). The combined organic fractions were washed with brine (15 mL) and dried (Na 2 SO 4 ), filtered and the solvent was removed under reduced pressure. 
Transactivation of NK cells
The production of IFN-γ by NK cells was determined following i.v. delivery of 1 µg lipids to C57 BL/6 mice, as previously described. 28 . Single cell suspensions were generated from the spleen and liver of mice at either 24 h or 48 h post injection. Abs for flow cytometry were from eBioscience (NK1.1, DX5, TCRb, B220, IFN-γ) and intracellular cytokine staining was carried out according to the manufacturer's protocol. Flow cytometry was performed on a CyAn (Dako) and analysed using FlowJo software.
Supplementary Figure 1 . Wildtype C57 BL/6 mice (n = 3/group) were injected i.v. with 1 µg ThrCer, ThrCer-thioamide (11) or ThrCer-carbamate (13). The transactivation of NK cells in the spleen and liver were determined by IFN-γ intracellular cytokine staining using FACS. In addition, IFN-γ levels in blood serum were determined by ELISA at 24 h and 33 h post-injection.
Statistical Analysis
All statistical analyses were preformed using Graphpad Prism software version 5.0. Student's t-test with two-tailed analysis was used to compare the level of significance between data sets. All p-values <0.05 were considered significant.
